The genomic landscape of tuberous sclerosis complex

Area of Science:

• Genetics
• Oncology
• Pathology

Background:

• Tuberous sclerosis complex (TSC) is a rare genetic disorder characterized by benign tumor growth and debilitating symptoms.
• Mutations in TSC1 or TSC2 genes initiate the disease, leading to MTOR pathway activation, though secondary genetic events are not always present.

Purpose of the Study:

• To comprehensively analyze the genomic landscape of hamartomas in Tuberous sclerosis complex.
• To identify conserved molecular signatures across different TSC lesion types.
• To investigate the role of neuroinflammation in TSC-associated brain tumors.

Main Methods:

• Genomic profiling of TSC hamartomas.
• Analysis of somatic mutational burden and chromosomal aberrations.
• Computational analysis of molecular signatures for cellular heterogeneity and origin.
• Examination of immune datasets for neuroinflammation.

Main Results:

• TSC lesions exhibit a low somatic mutational burden compared to carcinomas.
• A subset of TSC lesions displays large-scale chromosomal aberrations.
• Conserved molecular signatures were identified for distinct TSC lesion types.
• Significant neuroinflammation was detected in TSC-associated brain tumors.

Conclusions:

• The study provides a detailed molecular catalogue of TSC hamartomas.
• Findings offer insights into the cellular heterogeneity and cell-of-origin for TSC lesions.
• The research establishes a framework unifying genomic and transcriptomic data for complex tumors like those in TSC.
• Identified neuroinflammation suggests potential therapeutic targets for TSC brain tumors.